Pixarbio Corp, Corporation just filed form D for $40.00 million equity financing. This is a new filing. Pixarbio was able to fundraise $7.19 million so far. That is 17.97% of the fundraising. The total private offering amount was $40.00 million. The form was filed on 2016-11-17. The reason for the financing was: The offering terminated on October 30, 2016.. The fundraising still has about $32.81 million more and is not closed yet. We have to wait more to see if the offering will be fully taken.
Pixarbio is based in Massachusetts. The company’s business is Other Health Care. The D form was signed by Francis M Reynolds Chief Executive Officer. The company was incorporated in 2014. The filler’s address is: 200 Boston Avenue, Suite 1875, Medford, Ma, Massachusetts, 02155. Francis M. Reynolds is the related person in the form and it has address: 200 Boston Avenue, Suite 1875, Medford, Ma, Massachusetts, 02155. Link to Pixarbio Filing: 000168993616000001.
Analysis of Pixarbio Offering
On average, companies in the Other Health Care sector, sell 68.60% of the total offering size. Pixarbio sold 17.97% of the offering. The fundraising is still open. The average investment floor size for companies in the Other Health Care industry is $1.16 million. The total amount raised is 519.49% bigger than the average for companies in the Other Health Care sector. The minimum investment for this financing is set at $100000. If you know more about the reasons for the fundraising, please comment below.
What is Form D? What It Is Used For
Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.
Why Fundraising Reporting Is Good For Pixarbio Also
The Form D signed by Francis M Reynolds might help Pixarbio Corp’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.